Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
822 | 11902 | 28.6 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CALCIUM ANTAGONISTS | authKW | 401100 | 4% | 31% | 509 |
2 | CALCIUM CHANNEL BLOCKERS | authKW | 241249 | 4% | 20% | 473 |
3 | NIFEDIPINE | authKW | 182580 | 3% | 18% | 394 |
4 | AMLODIPINE | authKW | 174868 | 2% | 24% | 282 |
5 | LERCANIDIPINE | authKW | 172605 | 1% | 71% | 95 |
6 | DILTIAZEM | authKW | 167524 | 2% | 25% | 262 |
7 | ISRADIPINE | authKW | 148686 | 1% | 42% | 138 |
8 | CILNIDIPINE | authKW | 147111 | 1% | 77% | 75 |
9 | LACIDIPINE | authKW | 140823 | 1% | 53% | 103 |
10 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | journal | 138794 | 6% | 7% | 773 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 61374 | 42% | 1% | 5042 |
2 | Cardiac & Cardiovascular System | 48715 | 26% | 1% | 3065 |
3 | Peripheral Vascular Diseases | 14559 | 11% | 1% | 1293 |
4 | Medicine, General & Internal | 3947 | 10% | 0% | 1183 |
5 | Emergency Medicine | 1259 | 2% | 0% | 185 |
6 | Chemistry, Medicinal | 1120 | 4% | 0% | 434 |
7 | Toxicology | 1060 | 4% | 0% | 430 |
8 | Medicine, Research & Experimental | 857 | 4% | 0% | 520 |
9 | Chemistry, Analytical | 622 | 5% | 0% | 556 |
10 | Physiology | 158 | 2% | 0% | 278 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERCELLULAR INTERACT | 10254 | 0% | 100% | 4 |
2 | MECH ATHEROGENESIS | 7691 | 0% | 100% | 3 |
3 | ANTIOXIDANT PHARMACOL | 5767 | 0% | 75% | 3 |
4 | CLIN PHARMACOL GERIATR MED | 5767 | 0% | 75% | 3 |
5 | CARDIOLMEMBRANE BIOPHYS | 5127 | 0% | 100% | 2 |
6 | PHYSIOL BIOCHEM SURG | 5127 | 0% | 100% | 2 |
7 | SPRINT STUDY GRP | 5127 | 0% | 100% | 2 |
8 | ANALYT PHARMACOKINET | 4612 | 0% | 60% | 3 |
9 | MED BIOCHEM CARDIOVASC BIOL | 4606 | 0% | 30% | 6 |
10 | PHARM BIOCHEM PHARMACOL | 3724 | 0% | 36% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 138794 | 6% | 7% | 773 |
2 | AMERICAN JOURNAL OF CARDIOLOGY | 21299 | 4% | 2% | 477 |
3 | CARDIOVASCULAR DRUGS AND THERAPY | 21143 | 1% | 7% | 127 |
4 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 18628 | 2% | 4% | 188 |
5 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 15817 | 2% | 3% | 211 |
6 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 12024 | 1% | 3% | 145 |
7 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 11342 | 2% | 2% | 192 |
8 | JOURNAL OF HYPERTENSION | 10824 | 2% | 2% | 205 |
9 | JOURNAL OF HUMAN HYPERTENSION | 10731 | 1% | 3% | 125 |
10 | DRUGS | 9772 | 1% | 3% | 148 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CALCIUM ANTAGONISTS | 401100 | 4% | 31% | 509 | Search CALCIUM+ANTAGONISTS | Search CALCIUM+ANTAGONISTS |
2 | CALCIUM CHANNEL BLOCKERS | 241249 | 4% | 20% | 473 | Search CALCIUM+CHANNEL+BLOCKERS | Search CALCIUM+CHANNEL+BLOCKERS |
3 | NIFEDIPINE | 182580 | 3% | 18% | 394 | Search NIFEDIPINE | Search NIFEDIPINE |
4 | AMLODIPINE | 174868 | 2% | 24% | 282 | Search AMLODIPINE | Search AMLODIPINE |
5 | LERCANIDIPINE | 172605 | 1% | 71% | 95 | Search LERCANIDIPINE | Search LERCANIDIPINE |
6 | DILTIAZEM | 167524 | 2% | 25% | 262 | Search DILTIAZEM | Search DILTIAZEM |
7 | ISRADIPINE | 148686 | 1% | 42% | 138 | Search ISRADIPINE | Search ISRADIPINE |
8 | CILNIDIPINE | 147111 | 1% | 77% | 75 | Search CILNIDIPINE | Search CILNIDIPINE |
9 | LACIDIPINE | 140823 | 1% | 53% | 103 | Search LACIDIPINE | Search LACIDIPINE |
10 | VERAPAMIL | 101210 | 2% | 14% | 292 | Search VERAPAMIL | Search VERAPAMIL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ST-ONGE, M , DUBE, PA , GOSELIN, S , GUIMONT, C , GODWIN, J , ARCHAMBAULT, PM , CHAUNY, JM , FRENETTE, AJ , DARVEAU, M , LE SAGE, N , ET AL (2014) TREATMENT FOR CALCIUM CHANNEL BLOCKER POISONING: A SYSTEMATIC REVIEW.CLINICAL TOXICOLOGY. VOL. 52. ISSUE 9. P. 926 -944 | 101 | 80% | 19 |
2 | OLSON, KR , ERDMAN, AR , WOOLF, AD , SCHARMAN, EJ , CHRISTIANSON, G , CARAVATI, EM , WAX, PM , BOOZE, LL , MANOGUERRA, AS , KEYES, DC , ET AL (2005) CALCIUM CHANNEL BLOCKER INGESTION: AN EVIDENCE-BASED CONSENSUS GUIDELINE FOR OUT-OF-HOSPITAL MANAGEMENT.CLINICAL TOXICOLOGY. VOL. 43. ISSUE 7. P. 797-822 | 97 | 94% | 37 |
3 | GODFRAIND, T , MILLER, R , WIBO, M , (1986) CALCIUM ANTAGONISM AND CALCIUM ENTRY BLOCKADE.PHARMACOLOGICAL REVIEWS. VOL. 38. ISSUE 4. P. 321-416 | 254 | 34% | 1121 |
4 | SORKIN, EM , CLISSOLD, SP , BROGDEN, RN , (1985) NIFEDIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY, IN ISCHEMIC HEART-DISEASE, HYPERTENSION AND RELATED CARDIOVASCULAR DISORDERS.DRUGS. VOL. 30. ISSUE 3. P. 182-274 | 240 | 59% | 303 |
5 | SKOOG, CA , ENGEBRETSEN, KM , (2017) ARE VASOPRESSORS USEFUL IN TOXIN-INDUCED CARDIOGENIC SHOCK?.CLINICAL TOXICOLOGY. VOL. 55. ISSUE 4. P. 285 -304 | 82 | 81% | 0 |
6 | MCTAVISH, D , SORKIN, EM , (1989) VERAPAMIL - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION.DRUGS. VOL. 38. ISSUE 1. P. 19-76 | 186 | 67% | 140 |
7 | SZENTANDRASSY, N , NAGY, D , HEGYI, B , MAGYAR, J , BANYASZ, T , NANASI, PP , (2015) CLASS IV ANTIARRHYTHMIC AGENTS: NEW COMPOUNDS USING AN OLD STRATEGY.CURRENT PHARMACEUTICAL DESIGN. VOL. 21. ISSUE 8. P. 977 -1010 | 149 | 42% | 0 |
8 | BUCKLEY, MMT , GRANT, SM , GOA, KL , MCTAVISH, D , SORKIN, EM , (1990) DILTIAZEM - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 39. ISSUE 5. P. 757-806 | 164 | 61% | 147 |
9 | MARIK, PE , RIVERA, R , (2011) HYPERTENSIVE EMERGENCIES: AN UPDATE.CURRENT OPINION IN CRITICAL CARE. VOL. 17. ISSUE 6. P. 569-580 | 70 | 72% | 13 |
10 | FITTON, A , BENFIELD, P , (1990) ISRADIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE.DRUGS. VOL. 40. ISSUE 1. P. 31-74 | 116 | 80% | 90 |
Classes with closest relation at Level 2 |